AnaptysBio’s (ANAB) Neutral Rating Reiterated at HC Wainwright
AnaptysBio (NASDAQ:ANAB – Get Free Report)‘s stock had its “neutral” rating reissued by analysts at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They currently have a $19.00 ...
Wedbush Predicts AnaptysBio’s Q1 Earnings (NASDAQ:ANAB)
Equities research analysts at Wedbush lifted their Q1 2025 earnings estimates for AnaptysBio in a research note issued on Monday, February 3rd. Wedbush analyst D. Nierengarten now expects that the ...